Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension

被引:0
|
作者
Toth, K
Nemes, J
Czopf, L
Kapronczay, P
Kesmarky, G
Juricskay, I
机构
[1] Univ Pecs, Sch Med, Dept Med 1, Div Cardiol, H-7643 Pecs, Hungary
[2] Univ Pecs, Sch Med, Dept Med 1, Div Endocrinol, H-7643 Pecs, Hungary
关键词
essential hypertension; blood rheology; plasma lipids; doxazosin;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is known from previous studies that hemorheological parameters are altered in patients with essential hypertension. The hemorheological and hemodynamical effects of doxazosin, a selective alpha-1-adrenoreceptor blocker agent, was examined in twenty patients (mean age: 54 +/- 10 years) with essential hypertension. Hemorheologic (hematocrit, fibrinogen, plasma and whole blood viscosity) and hemodynamic (cardiac output and index, total peripheral resistance) parameters and plasma lipids were determined. The measurements were carried out before the beginning of the treatment, after 1 week and after 12 weeks treatment periods. Besides significant reduction of blood pressure and total peripheral resistance (p < 0.001), a decrease in cholesterol (p < 0.001) and triglyceride (p < 0.01) levels and a beneficial effect on hemorheological parameters was detected. Fibrinogen and plasma viscosity decreased significantly (p < 0.01). Hematocrit value was also lower after one week (p < 0.001), then an increase could be seen. Whole blood viscosity showed similar changes as hematocrit, but the degree of its final increase was slighter, which was supported by the significantly lower value of corrected blood viscosity (p < 0.05).
引用
收藏
页码:57 / 61
页数:5
相关论文
共 50 条
  • [41] HEMODYNAMIC AND URICOSURIC EFFECTS OF TICRYNAFEN IN ESSENTIAL HYPERTENSION
    HUANG, CM
    QUINTANILLA, A
    CHOCK, D
    ARMSTRONG, M
    UZEMAK, S
    GRECO, FD
    KIDNEY INTERNATIONAL, 1977, 12 (06) : 501 - 501
  • [42] SYSTEMIC HEMODYNAMIC EFFECTS OF BETHANIDINE IN ESSENTIAL HYPERTENSION
    CHRYSANT, SG
    NISHIYAMA, K
    ADAMOPOULOS, PN
    FROHLICH, ED
    CIRCULATION, 1975, 52 (01) : 137 - 140
  • [43] Analysis of hemodynamic parameters in patients with hypertension
    Trzeciak, Bartosz G.
    Czaja, Rafal
    Gutknecht, Piotr
    Molisz, Andrzej
    Nowicka-Sauer, Katarzyna
    Siebert, Janusz
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2014, 16 (03): : 300 - 301
  • [44] Effect of Atorvastatin on Hemorheological Parameters in Patients With Arterial Hypertension with Dyslipidemia
    Abrashkina, E. D.
    Shaalali, N.
    Pakhrova, O. A.
    Shutemova, E. A.
    Nazarova, O. A.
    KARDIOLOGIYA, 2010, 50 (05) : 25 - 28
  • [45] DOXAZOSIN IN PATIENTS WITH HYPERTENSION
    CONRAD, KA
    FAGAN, TC
    MACKIE, MJ
    MAYSHAR, PV
    LEE, S
    SOUHRADA, JF
    FALKNER, FC
    LAZAR, JD
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (01) : 21 - 24
  • [46] Atenolol vs nevibolol: Comparative influence on parameters of the cerebral hemodynamic in the patients with essential hypertension
    Sydorchuk, RI
    Taschuk, VK
    Sydorchuk, LP
    Sydorchuk, II
    JOURNAL OF HYPERTENSION, 2004, 22 : S111 - S111
  • [47] HEMODYNAMIC INVESTIGATIONS ON RELATIVES OF PATIENTS WITH ESSENTIAL HYPERTENSION
    OHLSSON, O
    HENNINGSEN, NC
    ACTA MEDICA SCANDINAVICA, 1979, : 7 - 12
  • [48] Hyperinsulinemia and changes of hemodynamic in patients with essential hypertension
    Obrezan, AG
    Bobrov, LL
    JOURNAL OF HYPERTENSION, 1998, 16 : S156 - S156
  • [49] GLUCOSE, INSULIN AND LIPID-METABOLISM IN DOXAZOSIN TREATED PATIENTS WITH HYPERTENSION
    SHIEH, SM
    SHEU, WHH
    SHEN, DDC
    FUH, MMT
    CHEN, YDI
    REAVEN, GM
    CIRCULATION, 1992, 86 (04) : 542 - 542
  • [50] Principal results of the hypertension and lipid trial (HALT): A multicenter study of doxazosin in patients with hypertension
    Levy, D
    Walmsley, P
    Levenstein, M
    AMERICAN HEART JOURNAL, 1996, 131 (05) : 966 - 973